{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T21:06:39Z","timestamp":1760043999836},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chirurg"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s00104-016-0168-3","type":"journal-article","created":{"date-parts":[[2016,5,2]],"date-time":"2016-05-02T10:40:36Z","timestamp":1462185636000},"page":"446-454","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pr\u00e4valenz der ASS-Low-Response in der Gef\u00e4\u00dfchirurgie"],"prefix":"10.1007","volume":"87","author":[{"given":"T.","family":"Hummel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. H.","family":"Meves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"R\u00fcdiger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"M\u00fcgge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mumme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Burkert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"M\u00fchlberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Neubauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,2]]},"reference":[{"issue":"4","key":"168_CR1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/AC.67.4.2170686","volume":"67","author":"SI Al-Azzam","year":"2012","unstructured":"Al-Azzam SI, Alzoubi KH, Khabour O, Alowidi A, Tawalbeh D (2012) The prevalence and factors associated with aspirin resistance in patients premedicated with aspirin. Acta Cardiol 67(4):445\u2013448","journal-title":"Acta Cardiol"},{"issue":"2","key":"168_CR2","first-page":"CD000535","volume":"2015","author":"R Bedenis","year":"2015","unstructured":"Bedenis R, Lethaby A, Maxwell H, Acosta S, Prins MH (2015) Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery. Cochrane Database Sys Rev 2015(2):CD000535 doi:10.1002\/14651858.CD000535.pub3","journal-title":"Cochrane Database Sys Rev"},{"key":"168_CR3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.amjcard.2009.03.022","volume":"104","author":"I Ben-Dor","year":"2009","unstructured":"Ben-Dor I, Kleimann NS, Lev E (2009) Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and Clopidogrel therapy. Am J Cardiol 104:227\u2013233","journal-title":"Am J Cardiol"},{"issue":"18","key":"168_CR4","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1001\/jama.2009.623","volume":"301","author":"JS Berger","year":"2009","unstructured":"Berger JS, Krantz MJ, Kittelson JM, Hiatt WR (2009) Aspirin for the prevention of cardiovascular events in patients with peripheral artery Desease, a meta-analyses of randomized trials. JAMA 301(18):1909\u20131919","journal-title":"JAMA"},{"key":"168_CR5","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","volume":"348","author":"CAPRIE Steering Committee","year":"1996","unstructured":"CAPRIE Steering Committee (1996) A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348:1329\u20131339","journal-title":"Lancet"},{"key":"168_CR6","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1365-2796.2006.01763.x","volume":"261","author":"M Catalano","year":"2007","unstructured":"Catalano M, Born G, Peto R (2007) Critical Leg Ischaemia Prevention Study (CLIPS) Group. Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease: randomized, double-blind trial. J Intern Med 261:276\u2013284","journal-title":"J Intern Med"},{"issue":"37","key":"168_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta19370","volume":"19","author":"J Dretzke","year":"2015","unstructured":"Dretzke J, Riley RD, Lordkipanidz\u00e9 M, Jowett S, O\u2019Donnell J, Ensor J, Moloney E, Price M, Raichand S, Hodgkinson J, Bayliss S, Fitzmaurice D, Moore D (2015) The prognostic utility of tests of platelet function for the detection of \u2018aspirin resistance\u2019 in patients with established cardiovascular or cerebrovascular disease: a systematic review and economic evaluation. Health Technol Assess 19(37):1\u2013366","journal-title":"Health Technol Assess"},{"key":"168_CR8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.pharmthera.2011.01.011","volume":"130","author":"R FitzGerald","year":"2011","unstructured":"FitzGerald R, Pirmohamed M (2011) Aspirin resistance: effect of clinical, biochemical and genetic factors. Pharmacol Ther 130:213\u2013225","journal-title":"Pharmacol Ther"},{"key":"168_CR9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1749-6632.2010.05733.x","volume":"1207","author":"ZG Franks","year":"2010","unstructured":"Franks ZG, Campbell RA, Weyrich AS, Rondina MT (2010) Platelet-leukocyte interactions link inflammatatory and thrombo-embolic events in ischemic stroce. Ann N Y Acad Sci 1207:11\u201317","journal-title":"Ann N Y Acad Sci"},{"key":"168_CR10","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1161\/CIRCULATIONAHA.105.596627","volume":"113","author":"AL Frelinger","year":"2006","unstructured":"Frelinger AL, Furman MI, Linden MD, Li Y, Fox ML, Barnard MR, Michelson AD (2006) Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1 and cyclooxygenase 2\u2011independent pathway. A 700-patient study of aspirin resistance. Circulation 113:2888\u20132896","journal-title":"Circulation"},{"issue":"4","key":"168_CR11","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/01.ftd.0000158084.84071.41","volume":"27","author":"J Gola\u0144ski","year":"2005","unstructured":"Gola\u0144ski J, Ch\u0142opicki S, Gola\u0144ski R, Gresner P, Iwaszkiewicz A, Watala C (2005) Resistance to aspirin in patients after coronary artery bypass grafting is transient: impact on the monitoring of aspirin antiplatelet therapy. Ther Drug Monit 27(4):484\u2013490","journal-title":"Ther Drug Monit"},{"key":"168_CR12","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jacc.2008.05.032","volume":"25","author":"AM Gori","year":"2008","unstructured":"Gori AM, Marcucci R, Migliorini A, Valenti R, Moschi G, Paniccia R, Buonamici P, Gensini GF, Vergara R, Abbate R, Antoniucci D (2008) Incidence and clinical impact of dual nonresponsiveness to aspirin and clopidogrel in patients with drug-eluting stents. J Am Coll Cardiol 25:734\u2013739","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"168_CR13","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1540-8183.2006.00181.x","volume":"19","author":"PA Gurbel","year":"2006","unstructured":"Gurbel PA, Tantry US (2006) Aspirin and clopidogrel resistance: consideration and management. J Interv Cardiol 19(5):439\u2013448","journal-title":"J Interv Cardiol"},{"key":"168_CR14","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0140-6736(06)68040-9","volume":"367","author":"GJ Hankey","year":"2006","unstructured":"Hankey GJ, Eikelboom JW (2006) Aspirin resistance. Lancet 367:606\u2013617","journal-title":"Lancet"},{"issue":"9","key":"168_CR15","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/jama.2009.261","volume":"301","author":"PM Ho","year":"2009","unstructured":"Ho PM, Maddox TM, Wang L, Fihn SD, Jesse RL, Peterson ED, Rumsfeld JS (2009) Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA 301(9):937\u2013944","journal-title":"JAMA"},{"key":"168_CR16","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ahj.2006.10.040","volume":"153","author":"MM Hovens","year":"2007","unstructured":"Hovens MM, Snoep JD, Eikenboom JC, van der Bom JG, Mertens BJ, Huisman MV (2007) Prevalence of persistent platelet reactivity despite use of aspirin: a systematic review. Am Heart J 153:175\u2013181","journal-title":"Am Heart J"},{"key":"168_CR17","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1373\/clinchem.2006.081059","volume":"53","author":"BT Ivandic","year":"2007","unstructured":"Ivandic BT, Giannitsis E, Schlick P, Staritz P, Katus HA, Hohfeld T (2007) Determination of aspirin responsiveness by use of whole blood platelet aggregometry. Clin Chem 53:614\u2013619","journal-title":"Clin Chem"},{"key":"168_CR18","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1373\/clinchem.2008.115089","volume":"55","author":"BT Ivandic","year":"2009","unstructured":"Ivandic BT, Sausemuth M, Ibrahim H, Giannitsis E, Gawaz M, Kantus HA (2009) Dual antiplatelet drug resistance is a risk factor for cardiovascular events after percutaneous coronary intervention. Clin Chem 55:1171\u20131176","journal-title":"Clin Chem"},{"key":"168_CR19","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00270-013-0710-3","volume":"37","author":"D Karnabatidis","year":"2014","unstructured":"Karnabatidis D, Spiliopoulos S, Pastromas G, Kitrou P, Christeas N, Katsanos K, Siablis D (2014) Prevalence of Nonresponsiveness to aspirin in patients with symptomatic Perpheral arterial disease using true point of care testing. Cardiovasc Intervent Radiol 37:631\u2013638","journal-title":"Cardiovasc Intervent Radiol"},{"key":"168_CR20","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/bmj.39430.529549.BE","volume":"336","author":"G Krasopoulos","year":"2008","unstructured":"Krasopoulos G, Brister SJ, Beattie WS, Elliot RF, Buchanan MR (2008) Aspirin \u201cresistance\u201d and risk of cardiovascular morbidity: systemic review and meta-analyses. BMJ 336:195\u2013198","journal-title":"BMJ"},{"issue":"4","key":"168_CR21","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/eurheartj\/ehn562","volume":"30","author":"W Kuliczkowski","year":"2009","unstructured":"Kuliczkowski W, Witkowski A, Polonski L, Watala C, Filipiak K, Budaj A, Golanski J, Sitkiewicz D, Pregowski J, Gorski J, Zembala M, Opolski G, Huber K, Arnesen H, Kristensen SD, De Caterina R (2009) Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology. Eur Heart J 30(4):426\u2013435","journal-title":"Eur Heart J"},{"key":"168_CR22","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1093\/eurheartj\/ehm226","volume":"28","author":"M Lordkipanidz\u00e9","year":"2007","unstructured":"Lordkipanidz\u00e9 M, Pharand C, Schampaert E, Turgeon J, Palisaitis DA, Diodati JG (2007) A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease. Eur Heart J 28:1702\u20131708","journal-title":"Eur Heart J"},{"key":"168_CR23","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1365-2141.2004.04983.x","volume":"125","author":"DJ McCabe","year":"2004","unstructured":"McCabe DJ, Harrison P, Mackie IJ, Sidhu PS, Purdy G, Lawrie AS, Watt H, Brown MM, Machin SJ (2004) Platelet degranulation and monocyte-platelet complex formation are increased in the acute and convalescent phases after ischaemic stroke or transient ischaemic attack. Br J Haematol 125:777\u2013787","journal-title":"Br J Haematol"},{"key":"168_CR24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1160\/TH11-06-0436","volume":"107","author":"SH Meves","year":"2012","unstructured":"Meves SH, Overbeck U, Endres HG, Krogias C, Neubauer H (2012) Dose-dependent effect of early antiplatelet therapy in acute ischaemic stroke. Thromb Haemost 107:69\u201379","journal-title":"Thromb Haemost"},{"key":"168_CR25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1160\/TH03-12-0758","volume":"92","author":"DA Payne","year":"2004","unstructured":"Payne DA, Jones CI, Hayes PD, Webster SE, Naylor AR, Goodall AH (2004) Platelet inhibition by aspirin is diminished in patients during carotid surgery: a form of transient aspirin resistance? Thromb Haemost 92:89\u201396","journal-title":"Thromb Haemost"},{"key":"168_CR26","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.amjcard.2009.01.341","volume":"103","author":"MJ Price","year":"2009","unstructured":"Price MJ, Nayak KR, Barker CM, Kandzari DE, Teirstein PS (2009) Predictors of Heightened Platelet Reactivity Despite Dual-Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention. Am J Cardiol 103:1339\u20131343","journal-title":"Am J Cardiol"},{"key":"168_CR27","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1111\/j.1538-7836.2007.02694.x","volume":"5","author":"S Rajagopalan","year":"2007","unstructured":"Rajagopalan S, Ford I, Bachoo P, Hills GS, Croal B, Greaves M, Brittenden J (2007) Platelet activation, myocardial ischemic events and postoperative non-response to aspirin in patients undergoing major vascular surgery. J Thromb Haemost 5:2028\u20132035","journal-title":"J Thromb Haemost"},{"key":"168_CR28","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jvs.2007.05.039","volume":"46","author":"S Rajagopalan","year":"2007","unstructured":"Rajagopalan S, Mckay I, Ford I, Bachoo P, Greaves M, Brittenden J (2007) Platelet activation increases with the severity of peripheral arterial disease: Implications for clinical management. J Vasc Surg 46:485\u2013490","journal-title":"J Vasc Surg"},{"issue":"6","key":"168_CR29","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0049-3848(96)00102-8","volume":"82","author":"CB Reininger","year":"1996","unstructured":"Reininger CB, Graf J, Reininger AJ, Spannagl M, Steckmeier B, Schweiberer L (1996) Increased platelet and coagulatory activity indicate ongoing thrombogenesis in peripheral arterial disease. Thromb Res 82(6):523\u2013532","journal-title":"Thromb Res"},{"issue":"8","key":"168_CR30","first-page":"CD002071","volume":"15","author":"L Robertson","year":"2012","unstructured":"Robertson L, Ghouri MA, Kovacs F (2012) Antiplatelet and anticoagulant drugs for prevention of restenosis\/reocclusion following peripheral endovascular treatment. Cochrane Database Syst Rev 15(8):CD002071 doi:10.1002\/14651858.CD002071.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"168_CR31","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0002-9149(02)02718-2","volume":"90","author":"DC Sane","year":"2002","unstructured":"Sane DC, McKee SA, Malinin AI, Serebruany VL (2002) Frequency of aspirin resistance in patients with congestive heart failure treated with antecedent aspirin. Am J Cardiol 90:893\u2013895","journal-title":"Am J Cardiol"},{"key":"168_CR32","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1479-5876-6-46","volume":"6","author":"KA Schwartz","year":"2008","unstructured":"Schwartz KA, Schwartz DE, Barber K, Reeves M, De Franco AC (2008) Non-compliance is the predominant cause of aspirin resistance in chronic coronary arterial disease patients. J Transl Med 6:46","journal-title":"J Transl Med"},{"key":"168_CR33","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1160\/TH11-01-0040","volume":"106","author":"D Sibbing","year":"2011","unstructured":"Sibbing D, Byrne RA, Bernlochner I, Kastrati A (2011) High platelet reactivity and clinical outcome \u2013 Fact and fiction. Thromb Haemost 106:191\u2013202","journal-title":"Thromb Haemost"},{"issue":"15","key":"168_CR34","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1001\/archinte.167.15.1593","volume":"167","author":"JD Snoep","year":"2007","unstructured":"Snoep JD, Hovens MMC, Eikenboom JCJ, Van der Bom JG, Huisman MV (2007) Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events \u2013 a systematic review and meta-analysis. Arch Intern Med 167(15):1593\u20131599","journal-title":"Arch Intern Med"},{"key":"168_CR35","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ahj.2007.04.014","volume":"154","author":"JD Snoep","year":"2007","unstructured":"Snoep JD, Hovens MM, Eikenboom JC, van der Bom JG, Juema JW, Huisman MV (2007) Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: a systematic review and meta-analyses. Am Heart J 154:221\u2013231","journal-title":"Am Heart J"},{"key":"168_CR36","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0140-6736(99)07199-8","volume":"355","author":"MJD Tangelder","year":"2000","unstructured":"Tangelder MJD, Algra A, Lawson JA, Eikelboom BC et al (2000) Dutch BOA Study investigators: Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral anticoagulants or Aspirin study): a randomised trial. Lancet 355:346\u2013351","journal-title":"Lancet"},{"key":"168_CR37","first-page":"18","volume":"7","author":"A Visona","year":"2009","unstructured":"Visona A, Tonello D, Zalunardo B, Irsara S, Liessi G, Marigo L, Zotta L (2009) Antithrombotic treatment before and after peripheral artery percutaneous angioplasty. Blood Transfus 7:18\u201323","journal-title":"Blood Transfus"},{"key":"168_CR38","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/hrt.2009.181107","volume":"96","author":"M W\u00fcrtz","year":"2010","unstructured":"W\u00fcrtz M, Grove EL, Kristensen SD, Hvas A\u2011M (2010) The antiplatelet effect of aspirin is reduced by proton pump inhibitors in patients with coronary artery diseases. Heart 96:368\u2013371","journal-title":"Heart"},{"key":"168_CR39","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.thromres.2011.08.019","volume":"129","author":"M W\u00fcrtz","year":"2012","unstructured":"W\u00fcrtz M, Hvas AM, Kristensen SD, Grove EL (2012) Platelet aggregation is dependent on platelet count in patients with coronary artery disease. Thromb Res 129:56\u201361","journal-title":"Thromb Res"},{"key":"168_CR40","volume-title":"S3-Leitlinie \u201eExtracranielle Carotisstenose; Diagnostik, Therapie und Nachsorge\u201c","author":"Deutsche Gesellschaft f\u00fcr Gef\u00e4\u00dfchirurgie und Gef\u00e4\u00dfmedizin","year":"2012","unstructured":"Deutsche Gesellschaft f\u00fcr Gef\u00e4\u00dfchirurgie und Gef\u00e4\u00dfmedizin (2012) S3-Leitlinie \u201eExtracranielle Carotisstenose; Diagnostik, Therapie und Nachsorge\u201c. www.awmf.org\/leitlinien\/detail\/ll\/004-028.html . Zugegriffen: 8.11.2015"},{"key":"168_CR41","volume-title":"S3-Leitlinie \u201ePeriphere arterielle Verschlusskrankheit (PAVK), Diagnostik und Therapie\u201c","author":"Deutsche Gesellschaft f\u00fcr Angiologie","year":"2015","unstructured":"Deutsche Gesellschaft f\u00fcr Angiologie (2015) S3-Leitlinie \u201ePeriphere arterielle Verschlusskrankheit (PAVK), Diagnostik und Therapie\u201c. www.awmf.org\/leitlinien\/detail\/ll\/065-003.html . Zugegriffen: 8.11.2015"},{"key":"168_CR42","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1160\/TH08-01-0056","volume":"100","author":"N Zimmermann","year":"2008","unstructured":"Zimmermann N, Hohfeld T (2008) Clinical implications of aspirin resistance. Thromb Haemost 100:379\u2013390","journal-title":"Thromb Haemost"}],"container-title":["Der Chirurg"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-016-0168-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00104-016-0168-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-016-0168-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T06:51:27Z","timestamp":1567839087000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00104-016-0168-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["168"],"URL":"https:\/\/doi.org\/10.1007\/s00104-016-0168-3","relation":{},"ISSN":["0009-4722","1433-0385"],"issn-type":[{"value":"0009-4722","type":"print"},{"value":"1433-0385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}